Biocon’s path to affordable innovation – A conversation with Steve Usdin, Senior Editor at BioCentury Publications
* freely available with registration
Biocon’s path to affordable innovation – A conversation with Steve Usdin, Senior Editor at BioCentury Publications
* freely available with registration
Kiran Mazumdar-Shaw: A Leading Woman in Science Making Global Impact
Kiran Mazumdar Shaw talks on the “Economics of a Pandemic” at the Bloomberg India Economic Forum.
Kiran Mazumdar Shaw Interview
Courtesy BBC News
Walk The Talk with Kiran Mazumdar Shaw by Shekhar Gupta
Courtesy NDTV
Meet Kiran Mazumdar-Shaw, India’s richest self-made woman, founder of biopharma firm Biocon
Courtesy ZEE NEWS
Kiran Mazumdar Shaw with Sadhguru in Challenging Times
In Pursuit Of Excellence | Uncut conversation – Kiran M Shaw with Vijay Amritraj
Courtesy: Louis Philippe
Women in Chemistry: Kiran Mazumdar-Shaw
Interview With Kiran Mazumdar Shaw on ‘The Secret to Success’
Courtesy Femina
Kiran Mazumdar-Shaw In Conversation with Sadhguru, 2017
Kiran Mazumdar Shaw Journey Video
Courtesy Her Power
Pride of India – Kiran Mazumdar Shaw
Courtesy Indian Diplomacy
Biocon’s Kiran Mazumdar Shaw Speaks On Winning EY World Entrepreneur Of The Year Award
Courtesy CNBC-TV18
Biocon’s Kiran Mazumdar-Shaw: Developing Female Talent
Courtesy Harvard Business School
Know more
about us
You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.